Oric Pharmaceuticals (ORIC) closed at $13.17 on October 23, 2026, down 3.4% from the previous close, on volume of 1,284,845 shares (30-day average 1,486,588).
Data as of October 23, 2026.
23-Oct-2026
Analysts Are Bullish on Top Healthcare Stocks: Korro Bio (KRRO), Oric Pharmaceuticals (ORIC)
TipRanks (Fri, 23-Oct 10:40 AM ET)
Oric Highlights Strong Enozertinib Data, Eyes Phase 3
TipRanks (Fri, 23-Oct 8:33 AM ET)
Globe Newswire (Fri, 23-Oct 3:15 AM ET)
Globe Newswire (Fri, 23-Oct 3:15 AM ET)
TipRanks (Thu, 22-Oct 9:50 AM ET)
Globe Newswire (Mon, 19-Oct 8:00 AM ET)
Globe Newswire (Mon, 5-Oct 4:01 PM ET)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 2-Oct 4:30 PM ET)
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Globe Newswire (Wed, 2-Sep 4:05 PM ET)
ORIC Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates
Globe Newswire (Mon, 3-Aug 4:05 PM ET)
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Oric Pharmaceuticals trades on the NASDAQ stock market under the symbol ORIC.
As of October 23, 2026, ORIC stock price declined to $13.17 with 1,284,845 million shares trading.
ORIC has a beta of 0.51, meaning it tends to be less sensitive to market movements. ORIC has a correlation of 0.01 to the broad based SPY ETF.
ORIC has a market cap of $1.36 billion. This is considered a Small Cap stock.
In the last 3 years, ORIC traded as high as $16.65 and as low as $3.90.
The top ETF exchange traded funds that ORIC belongs to (by Net Assets): VTI, XBI, IWM, VXF, DFAS.
ORIC has underperformed the market in the last year with a return of +6.0%, while SPY returned +14.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ORIC shares. However, ORIC has outperformed the market in the last 3 month and 2 week periods, returning +20.9% and +9.8%, while SPY returned +3.2% and -2.4%, respectively. This indicates ORIC has been having a stronger performance recently.
ORIC support price is $12.97 and resistance is $14.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ORIC shares will trade within this expected range on the day.
